{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:44:26Z","timestamp":1791204266216,"version":"4.2.0"},"reference-count":69,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glucocorticoids are potent anti-inflammatory agents that are widely used for the treatment of many inflammatory, autoimmune, and neoplastic disorders. However, their beneficial effect is associated with several side effects, including an increased risk of cardiovascular complications, such as myocardial infarction and stroke. Whether their use also contributes to a procoagulant state, and therefore increases the risk of venous thromboembolism (VTE), is still a matter of debate. As an increased risk of venous thrombotic events is described in patients with Cushing's syndrome, which is characterized by endogenous hypercortisolism, it is reasonable to speculate that the chronic administration of glucocorticoids may induce a hypercoagulable state. However, it seems virtually impossible to separate the role of the drug from the underlying condition, which itself predisposes to the development of VTE. Actually, some evidence suggests that the use of exogenous glucocorticoids for the treatment of underlying disease and its exacerbations may further amplify the risk of VTE. Moreover, a procoagulant state has also been reported in healthy participants receiving oral glucocorticoids versus placebo. We have performed a concise narrative review on available data on the influence of exogenous glucocorticoids on hemostasis and their clinical impact on the risk of VTE.<\/jats:p>","DOI":"10.1055\/s-0040-1722270","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T21:20:43Z","timestamp":1619212843000},"page":"654-661","source":"Crossref","is-referenced-by-count":40,"title":["Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review"],"prefix":"10.1055","volume":"47","author":[{"given":"Chiara","family":"Simion","sequence":"additional","affiliation":[{"name":"Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[{"name":"Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bensi","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bellio","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pontarin","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spiezia","sequence":"additional","affiliation":[{"name":"Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[{"name":"Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"S Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"S A Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"T P van Staa","year":"2000","journal-title":"QJM"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"B R Walker","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","article-title":"Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors","volume":"8","author":"B van Zaane","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"R van der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"M11","DOI":"10.1530\/EJE-15-0198","article-title":"Adverse effects of glucocorticoids: coagulopathy","volume":"173","author":"M CA Coelho","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4939-2895-8_13","article-title":"Glucocorticoids and the cardiovascular system","volume":"872","author":"J E Goodwin","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"M Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"A Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study","volume":"96","author":"D JF Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1378\/chest.12-1446","article-title":"Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study","volume":"143","author":"D JF Stuijver","year":"2013","journal-title":"Chest"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jth.13265","article-title":"The influence of corticosteroids on hemostasis in healthy subjects","volume":"14","author":"C J Majoor","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","article-title":"Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers","volume":"118","author":"D J Brotman","year":"2006","journal-title":"Thromb Res"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2265.2004.02168.x","article-title":"High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO\/ISH guidelines","volume":"61","author":"T Mancini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"R Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12020-015-0665-z","article-title":"A venous thromboembolism risk assessment model for patients with Cushing's syndrome","volume":"52","author":"M Zilio","year":"2016","journal-title":"Endocrine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous cushing's syndrome: a systematic meta-analysis","volume":"9","author":"J Wagner","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"G E Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing's syndrome: a systematic review","volume":"94","author":"B Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"G H Guyatt","year":"2012","journal-title":"Chest"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11102-014-0600-y","article-title":"Perioperative thromboprophylaxis in Cushing's disease: what we did and what we are doing?","volume":"18","author":"M Barbot","year":"2015","journal-title":"Pituitary"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"A M Isidori","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.0954-6820.1985.tb03254.x","article-title":"Haemostatic parameters in Cushing's syndrome","volume":"217","author":"E Ikkala","year":"1985","journal-title":"Acta Med Scand"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001721-199212000-00013","article-title":"The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state","volume":"3","author":"G M Patrassi","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001721-199904000-00006","article-title":"Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome","volume":"10","author":"A Casonato","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"08","key":"ref27","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome","volume":"87","author":"M Boscaro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"D Kastelan","year":"2009","journal-title":"Endocrine"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2011-2753","article-title":"The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy","volume":"97","author":"R van der Pas","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpeds.2016.06.087","article-title":"Coagulation profile dynamics in pediatric patients with cushing syndrome: a prospective, observational comparative study","volume":"177","author":"L Birdwell","year":"2016","journal-title":"J Pediatr"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery","volume":"163","author":"L Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MBC.0b013e3283548dfc","article-title":"Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism","volume":"23","author":"A Chopra","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","article-title":"Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome","volume":"23","author":"L M Fatti","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","article-title":"Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels","volume":"32","author":"C Erem","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-013-0467-3","article-title":"Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?","volume":"17","author":"S Koutroumpi","year":"2014","journal-title":"Pituitary"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"A Tripodi","year":"2016","journal-title":"Clin Chem"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1183\/09031936.00150312","article-title":"Risk of deep vein thrombosis and pulmonary embolism in asthma","volume":"42","author":"C J Majoor","year":"2013","journal-title":"Eur Respir J"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1183\/09031936.00043313","article-title":"Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study","volume":"43","author":"W-S Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"01","key":"ref39","first-page":"63","article-title":"Allergy and Venous Thromboembolism: A Casual or Causative Association","volume":"42","author":"G Lippi","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1378\/chest.08-1516","article-title":"Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis","volume":"135","author":"J Rizkallah","year":"2009","journal-title":"Chest"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.amjmed.2012.03.007","article-title":"Venous thromboembolism in patients with chronic obstructive pulmonary disease","volume":"125","author":"G Piazza","year":"2012","journal-title":"Am J Med"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5603\/PiAP.2015.0078","article-title":"Arterial and venous thromboembolism in chronic obstructive pulmonary disease: from pathogenic mechanisms to prevention and treatment","volume":"83","author":"F Mejza","year":"2015","journal-title":"Pneumonol Alergol Pol"},{"issue":"14","key":"ref43","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4103\/0366-6999.235865","article-title":"Pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"131","author":"Y Q Cao","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"M J Grainge","year":"2010","journal-title":"Lancet"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"G C Nguyen","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"26","author":"K Cheng","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"07","key":"ref47","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/annrheumdis-2012-201669","article-title":"The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study","volume":"72","author":"H K Choi","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"39","key":"ref48","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1093\/eurheartj\/ehx145","article-title":"Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study","volume":"39","author":"A Ogdie","year":"2018","journal-title":"Eur Heart J"},{"key":"ref49","first-page":"keaa262","article-title":"The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study","author":"L Li","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"05","key":"ref50","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1538-7836.2012.04666.x","article-title":"Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study","volume":"10","author":"S A Johannesdottir","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"B Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1358863X15573838","article-title":"Venous thromboembolism in systemic autoimmune diseases: a narrative review with emphasis on primary systemic vasculitides","volume":"20","author":"H Tamaki","year":"2015","journal-title":"Vasc Med"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/ijdvl.IJDVL_827_16","article-title":"Risk of venous thromboembolism in patients with bullous pemphigoid: a systematic review and meta-analysis","volume":"84","author":"P Ungprasert","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0002-9343(50)90290-7","article-title":"Hypercoagulability of the blood associated with ACTH and cortisone therapy","volume":"9","author":"S W Cosgriff","year":"1950","journal-title":"Am J Med"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.1951.03670270014006","article-title":"Thromboembolic complications associated with ACTH and cortisone therapy","volume":"147","author":"S W Cosgriff","year":"1951","journal-title":"J Am Med Assoc"},{"issue":"09","key":"ref56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"C Huerta","year":"2007","journal-title":"Arch Intern Med"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000015982","article-title":"Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Role of lumbar puncture or intravenous corticosteroid treatment","volume":"9","author":"J F Albucher","year":"1999","journal-title":"Cerebrovasc Dis"},{"issue":"01","key":"ref58","first-page":"88","article-title":"Cerebral venous thrombosis after high dose steroid in multiple sclerosis: a case report","volume":"17","author":"S Gazioglu","year":"2013","journal-title":"Hippokratia"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"785459","DOI":"10.1155\/2011\/785459","article-title":"Venous thrombosis in multiple sclerosis patients after high-dose intravenous methylprednisolone: the preventive effect of enoxaparin","volume":"2011","author":"H Kalanie","year":"2011","journal-title":"Thrombosis"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.17712\/nsj.2016.1.20150534","article-title":"Cerebral venous sinus thrombosis in a patient with Cushings syndrome due to topical steroid","volume":"21","author":"A H Al-Khalaf","year":"2016","journal-title":"Neurosciences (Riyadh)"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2016.02.010","article-title":"Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism","volume":"140","author":"M MS Sneeboer","year":"2016","journal-title":"Thromb Res"},{"issue":"22","key":"ref62","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"V Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"M Di Nisio","year":"2016","journal-title":"Lancet"},{"issue":"08","key":"ref64","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/jth.13741","article-title":"Chronic complications of venous thromboembolism","volume":"15","author":"M-P Winter","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"P Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"issue":"18","key":"ref66","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"S R Kahn","year":"2014","journal-title":"Circulation"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"S R Kahn","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.2019002364","article-title":"Long-term treatment of venous thromboembolism","volume":"135","author":"C Kearon","year":"2020","journal-title":"Blood"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12185-018-2540-1","article-title":"Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone","volume":"109","author":"J Shin","year":"2019","journal-title":"Int J Hematol"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1722270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:49:01Z","timestamp":1630522141000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1722270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":69,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2021,9,1]]},"published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1722270","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}